Point72 (Difc) LTD Immuneering Corp Transaction History
Point72 (Difc) LTD
- $2.81 Trillion
- Q2 2024
A detailed history of Point72 (Difc) LTD transactions in Immuneering Corp stock. As of the latest transaction made, Point72 (Difc) LTD holds 4,983 shares of IMRX stock, worth $9,318. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,983Holding current value
$9,318% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMRX
# of Institutions
54Shares Held
9.63MCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.88MShares$3.52 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.07MShares$2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny953KShares$1.78 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD859KShares$1.61 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY742KShares$1.39 Million0.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $49.4M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...